Patients without diabetes treated with GLP-1s for weight loss are remaining on the drugs without gaps, and switching drugs when needed may help sustain persistence.

A man from near Taunton says the healthcare system in the UK has treated him ‘unfairly’ after suffering with ‘severe, chronic’ pain for nearly two years.

Initiated US Phase 1/2a study of DLL3-targeting 212Pb-based Radio-DARPin candidate MP0712 for SCLC and other neuroendocrine cancers, co-developed with strategic partner Orano Med; initial data anticip ...

Bengaluru: As the LPG supply crisis continues, hospitals in the city are quietly putting contingency plans in place to ensure that the food supply for patients remains uninterrupted. From stocking ...

Scoping review shows clinicians and patients still worry about biosimilar insulin switching, devices and safety—evidence gaps ...

While the young adult spin on Star Trek started strong, the writers failed most of their characters ...